BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cheng S, Nethi SK, Rathi S, Layek B, Prabha S. Engineered Mesenchymal Stem Cells for Targeting Solid Tumors: Therapeutic Potential beyond Regenerative Therapy. J Pharmacol Exp Ther 2019;370:231-41. [PMID: 31175219 DOI: 10.1124/jpet.119.259796] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 5.7] [Reference Citation Analysis]
Number Citing Articles
1 de la Torre P, Pérez-Lorenzo MJ, Alcázar-Garrido Á, Flores AI. Cell-Based Nanoparticles Delivery Systems for Targeted Cancer Therapy: Lessons from Anti-Angiogenesis Treatments. Molecules 2020;25:E715. [PMID: 32046010 DOI: 10.3390/molecules25030715] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 11.0] [Reference Citation Analysis]
2 Blanco-Fernandez B, Cano-Torres I, Garrido C, Rubi-Sans G, Sanchez-Cid L, Guerra-Rebollo M, Rubio N, Blanco J, Perez-Amodio S, Mateos-Timoneda MA, Engel E. Engineered microtissues for the bystander therapy against cancer. Mater Sci Eng C Mater Biol Appl 2021;121:111854. [PMID: 33579487 DOI: 10.1016/j.msec.2020.111854] [Reference Citation Analysis]
3 Nethi SK, Bhatnagar S, Prabha S. Synthetic Receptor-Based Targeting Strategies to Improve Tumor Drug Delivery. AAPS PharmSciTech 2021;22:93. [PMID: 33683499 DOI: 10.1208/s12249-021-01919-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Hamilton G, Teufelsbauer M. Adipose-derived stromal/stem cells and extracellular vesicles for cancer therapy. Expert Opin Biol Ther 2021;:1-12. [PMID: 34236014 DOI: 10.1080/14712598.2021.1954156] [Reference Citation Analysis]
5 de la Torre P, Paris JL, Fernández-de la Torre M, Vallet-Regí M, Flores AI. Endostatin Genetically Engineered Placental Mesenchymal Stromal Cells Carrying Doxorubicin-Loaded Mesoporous Silica Nanoparticles for Combined Chemo- and Antiangiogenic Therapy. Pharmaceutics 2021;13:244. [PMID: 33578733 DOI: 10.3390/pharmaceutics13020244] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Ahmed GM, Abouauf EA, AbuBakr N, Fouad AM, Dörfer CE, Fawzy El-Sayed KM. Cell-Based Transplantation versus Cell Homing Approaches for Pulp-Dentin Complex Regeneration. Stem Cells Int 2021;2021:8483668. [PMID: 34646323 DOI: 10.1155/2021/8483668] [Reference Citation Analysis]
7 Adelipour M, Allameh A, Sheikhi A, Ranjbaran M, Naghashpour M, Nazeri Z, Mojiri-Forushani H, Golabi S. Role of the mesenchymal stem cells derived from adipose tissue in changing the rate of breast cancer cell proliferation and autophagy, in vitro and in vivo. Iran J Basic Med Sci 2021;24:98-107. [PMID: 33643577 DOI: 10.22038/ijbms.2020.51461.11678] [Reference Citation Analysis]
8 Mercer-Smith AR, Findlay IA, Bomba HN, Hingtgen SD. Intravenously Infused Stem Cells for Cancer Treatment. Stem Cell Rev Rep 2021. [PMID: 34138421 DOI: 10.1007/s12015-021-10192-0] [Reference Citation Analysis]
9 Borghese C, Casagrande N, Corona G, Aldinucci D. Adipose-Derived Stem Cells Primed with Paclitaxel Inhibit Ovarian Cancer Spheroid Growth and Overcome Paclitaxel Resistance. Pharmaceutics 2020;12:E401. [PMID: 32349462 DOI: 10.3390/pharmaceutics12050401] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
10 Zhang T, Lin R, Wu H, Jiang X, Gao J. Mesenchymal stem cells: a living carrier for active tumor-targeted delivery. Adv Drug Deliv Rev 2022;:114300. [PMID: 35447165 DOI: 10.1016/j.addr.2022.114300] [Reference Citation Analysis]
11 Takayama Y, Kusamori K, Nishikawa M. Mesenchymal stem/stromal cells as next-generation drug delivery vehicles for cancer therapeutics. Expert Opin Drug Deliv 2021;:1-16. [PMID: 34311638 DOI: 10.1080/17425247.2021.1960309] [Reference Citation Analysis]
12 Park SA, Han HR, Ahn S, Ryu CH, Jeun SS. Combination treatment with VPA and MSCs‑TRAIL could increase anti‑tumor effects against intracranial glioma. Oncol Rep 2021;45:869-78. [PMID: 33469674 DOI: 10.3892/or.2021.7937] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
13 Do AD, Kurniawati I, Hsieh CL, Wong TT, Lin YL, Sung SY. Application of Mesenchymal Stem Cells in Targeted Delivery to the Brain: Potential and Challenges of the Extracellular Vesicle-Based Approach for Brain Tumor Treatment. Int J Mol Sci 2021;22:11187. [PMID: 34681842 DOI: 10.3390/ijms222011187] [Reference Citation Analysis]
14 Cheng S, Nethi SK, Al-Kofahi M, Prabha S. Pharmacokinetic-Pharmacodynamic Modeling of Tumor Targeted Drug Delivery Using Nano-Engineered Mesenchymal Stem Cells. Pharmaceutics 2021;13:92. [PMID: 33445681 DOI: 10.3390/pharmaceutics13010092] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Heidari R, Gholamian Dehkordi N, Mohseni R, Safaei M. Engineering mesenchymal stem cells: a novel therapeutic approach in breast cancer. J Drug Target 2020;28:732-41. [PMID: 32463709 DOI: 10.1080/1061186X.2020.1775842] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Briquez PS, Hauert S, de Titta A, Gray LT, Alpar AT, Swartz MA, Hubbell JA. Engineering Targeting Materials for Therapeutic Cancer Vaccines. Front Bioeng Biotechnol. 2020;8:19. [PMID: 32117911 DOI: 10.3389/fbioe.2020.00019] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
17 Zhou T, Yuan Z, Weng J, Pei D, Du X, He C, Lai P. Challenges and advances in clinical applications of mesenchymal stromal cells. J Hematol Oncol. 2021;14:24. [PMID: 33579329 DOI: 10.1186/s13045-021-01037-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
18 Liesveld JL, Sharma N, Aljitawi OS. Stem cell homing: From physiology to therapeutics.Stem Cells. 2020;38:1241-1253. [PMID: 32526037 DOI: 10.1002/stem.3242] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 4.5] [Reference Citation Analysis]
19 Sahu A, Jeon J, Lee MS, Yang HS, Tae G. Nanozyme Impregnated Mesenchymal Stem Cells for Hepatic Ischemia-Reperfusion Injury Alleviation. ACS Appl Mater Interfaces 2021;13:25649-62. [PMID: 33974389 DOI: 10.1021/acsami.1c03027] [Reference Citation Analysis]